Puma Biotechnology (PBYI) Earnings Date, Estimates & Call Transcripts $3.02 +0.02 (+0.67%) (As of 11/25/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Puma Biotechnology Latest Earnings SummaryUpcoming Q4 Earnings DateMar. 6EstimatedActual EPS (Nov. 7) $0.41 Beat By $0.10 Consensus EPS (Nov. 7) $0.31 Puma Biotechnology posted Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.41, which topped analysts' consensus estimates of $0.31 by $0.10. Quarterly revenue was reported to be $80.50 million, above the consensus estimate of $71.32 million. With a trailing EPS of $0.48 and a P/E Ratio of 6.29, Puma Biotechnology's earnings are expected to grow 17.24% next year, from $0.29 to $0.34 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckPBYI Upcoming EarningsPuma Biotechnology's next earnings date is estimated for Thursday, March 6, 2025, based off prior year's reporting schedules. Get Puma Biotechnology Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Puma Biotechnology and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPBYI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PBYI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry Research"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the Puma Biotechnology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.22-$0.22-$0.22Q2 20241$0.13$0.13$0.13Q3 20241$0.09$0.09$0.09Q4 20241$0.18$0.18$0.18FY 20244$0.18$0.18$0.18Q1 20251$0.01$0.01$0.01Q2 20251$0.09$0.09$0.09Q3 20251$0.08$0.08$0.08Q4 20251$0.08$0.08$0.08FY 20254$0.26$0.26$0.26Q1 20261$0.10$0.10$0.10Q3 20261$0.24$0.24$0.24 Puma Biotechnology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/6/2025(Estimated)------- 11/7/2024Q3 2024$0.31$0.41+$0.10$0.41$71.32M$80.50M 8/1/2024Q2 2024-$0.0970-$0.09+$0.0070-$0.09$43.99M$47.10M 5/2/2024Q1 2024-$0.22-$0.10+$0.12-$0.10$41.53M$43.80M 2/29/2024Q4 2023$0.33$0.26 -$0.07$0.26$73.22M$72.20M 11/2/2023Q3 2023$0.08$0.12+$0.04$0.12$57.30M$56.10M 8/3/2023Q2 2023$0.02$0.05+$0.03$0.05$51.37M$54.60M Get the Latest News and Ratings for PBYI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Puma Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 5/4/2023Q1 2023-$0.10$0.03+$0.13$0.03$49.71M$52.80M 3/2/2023Q4 2022$0.06-$0.12 -$0.18-$0.12$57.10M$65.70M Puma Biotechnology Earnings - Frequently Asked Questions When is Puma Biotechnology's earnings date? Puma Biotechnology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates. Learn more on PBYI's earnings history. What guidance has Puma Biotechnology issued on next quarter's earnings? Puma Biotechnology updated its fourth quarter 2024 earnings guidance on Thursday, November, 7th. The company issued revenue guidance of $50.5 million-$55.0 million, compared to the consensus revenue estimate of $55.5 million. Did Puma Biotechnology beat their earnings estimates last quarter? In the previous quarter, Puma Biotechnology (NASDAQ:PBYI) reported $0.41 earnings per share (EPS) to beat the analysts' consensus estimate of $0.31 by $0.10. Learn more on analysts' earnings estimate vs. PBYI's actual earnings. How can I listen to Puma Biotechnology's earnings conference call? The conference call for Puma Biotechnology's latest earnings report can be listened to online. Listen to Conference Call How can I read Puma Biotechnology's conference call transcript? The conference call transcript for Puma Biotechnology's latest earnings report can be read online. Read Transcript How much revenue does Puma Biotechnology generate each year? Puma Biotechnology (NASDAQ:PBYI) has a recorded annual revenue of $235.60 million. How much profit does Puma Biotechnology generate each year? Puma Biotechnology (NASDAQ:PBYI) has a recorded net income of $21.59 million. PBYI has generated $0.48 earnings per share over the last four quarters. What is Puma Biotechnology's price-to-earnings ratio? Puma Biotechnology (NASDAQ:PBYI) has a trailing price-to-earnings ratio of 6.29 and a forward price-to-earnings ratio of 10.41. What is Puma Biotechnology's EPS forecast for next year? Puma Biotechnology's earnings are expected to grow from $0.29 per share to $0.34 per share in the next year, which is a 17.24% increase. ` More Earnings Resources from MarketBeat Related Companies IGM Biosciences Earnings Results ChromaDex Earnings Results Sana Biotechnology Earnings Results Astria Therapeutics Earnings Results Annexon Earnings Results Mereo BioPharma Group Earnings Results Organogenesis Earnings Results Humacyte Earnings Results ProKidney Earnings Results Monte Rosa Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report "This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" (Ad)What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the This page (NASDAQ:PBYI) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredFormer Trump advisor issues urgent warningElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Puma Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Puma Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBYI Stock Alerts